US FDA Acting Commissioner Pick Could Underscore Trump Team’s IT Focus

 
• By Ramsey Baghdadi

Sara Brenner has been a key figure in the FDA’s diagnostics team, but her choice as acting FDA commissioner likely has more to do with her background with advanced technology and comfort level with the tech-focused side of the Trump transition team.

Sara Brenner's technology background may have helped her become acting FDA commissioner. (Shutterstock)

More from US FDA

More from Digital Technologies